Loréal, O.; Cavey, T.; Robin, F.; Kenawi, M.; Guggenbuhl, P.; Brissot, P.
Iron as a Therapeutic Target in HFE-Related Hemochromatosis: Usual and Novel Aspects. Pharmaceuticals 2018, 11, 131.
https://doi.org/10.3390/ph11040131
AMA Style
Loréal O, Cavey T, Robin F, Kenawi M, Guggenbuhl P, Brissot P.
Iron as a Therapeutic Target in HFE-Related Hemochromatosis: Usual and Novel Aspects. Pharmaceuticals. 2018; 11(4):131.
https://doi.org/10.3390/ph11040131
Chicago/Turabian Style
Loréal, Olivier, Thibault Cavey, François Robin, Moussa Kenawi, Pascal Guggenbuhl, and Pierre Brissot.
2018. "Iron as a Therapeutic Target in HFE-Related Hemochromatosis: Usual and Novel Aspects" Pharmaceuticals 11, no. 4: 131.
https://doi.org/10.3390/ph11040131
APA Style
Loréal, O., Cavey, T., Robin, F., Kenawi, M., Guggenbuhl, P., & Brissot, P.
(2018). Iron as a Therapeutic Target in HFE-Related Hemochromatosis: Usual and Novel Aspects. Pharmaceuticals, 11(4), 131.
https://doi.org/10.3390/ph11040131